Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms in MenAlexander Bachmann, Jean de la Rosette The diagnosis and treatment of benign prostatic hyperplasia (BPH) is considered to be one of the most important topics in urology and afflicts millions of older men world-wide. Although it is not life threatening, its clinical manifestation as lower urinary tract symptoms (LUTS) reduces the patient's quality of life over many years. Patients often suffer from LUTS due to BPH for a long time. If left untreated, the patients are at significant risk of potentially severe complications. Over the last decade, new diagnostic approaches and treatment options such as prostate lasers have become more accepted in the urological community. This pocketbook provides an update of several aspects related with BPH / LUTS and covers the entire background, diagnostic process and treatment options available to patients suffering from LUTS due to BPH. It will give trainees in urology and general physicians a quick, concise but complete overview of diagnostic processes and recommended treatment options. |
Contents
LUTS BPH BPE BOO BPO | 1 |
2 Natural history of untreated BPH and its impact on LUTS | 7 |
3 Pathophysiology of BPH symptoms and symptom scores | 17 |
4 BPH PSA and the risk of having prostate cancer PCA | 25 |
5 Erectile dysfunction associated with LUTS and BPH | 33 |
6 OAB LUTS and BPHa paradigm shift | 37 |
7 Bladder outflow obstruction urodynamic studies and BPH | 43 |
8 Aging men and LUTS | 49 |
open prostatectomy | 95 |
transurethral resection of the prostate TURP | 101 |
Prostate laser | 109 |
Greenlight laser | 115 |
Holmium laser | 121 |
Thulium laser | 127 |
Diode laser | 131 |
21 Riskadapted management of BPH | 137 |
9 Risk factors associated with BPH | 53 |
subjective parameters | 59 |
objective parameters | 65 |
12 Watchful waiting and lifestyle issues associated with LUTS and BPH | 79 |
13 Medical treatment of LUTS and BPH | 85 |
Other editions - View all
Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms in Men Alexander Bachmann,Jean de la Rosette No preview available - 2011 |
Common terms and phrases
5ARIs a-blockers ablation acute urinary retention alfuzosin American Urological Association ARBs assessment benign prostatic enlargement benign prostatic hyperplasia benign prostatic obstruction bipolar BJU Int bladder outlet obstruction bleeding BPH/LUTS catheter CHAPTER clinical coagulation Complications of BPH Department of Urology detrusor overactivity diagnosis diode laser disease progression effects efficacy erectile dysfunction evaluation finasteride flow rate follow-up glands Gratzke histologic BPH HOLEP Holmium Holmium laser enucleation improvement increased IPSS long-term lower urinary tract LUTS/BPH Madersbacher medical treatment ml/s morbidity natural history nocturia open prostatectomy outcome overactive bladder parameters patients placebo prevalence Professor of Urology prostate cancer prostate volume prostatectomy prostatic hyperplasia BPH Qmax randomized receptor Reich residual urine risk factors Roehrborn CG Rosette studies syndrome tamsulosin technique tion tissue transurethral resection trial TURP urethral strictures urinary retention urinary tract infection urinary tract symptoms urodynamic Urol Urology vaporization voiding symptoms